$HZNP Recent Headlines Charting a bullish seco
Post# of 44955
Posted On: 04/15/2014 12:11:54 PM
$HZNP Recent Headlines
Charting a bullish second-quarter backdrop 12:34 p.m. April 1, 2014 - Michael Ashbaugh
Charting a bullish second-quarter backdrop 12:20 p.m. April 1, 2014 - Michael Ashbaugh
S&P 500 retests major support 12:47 p.m. March 27, 2014 - Michael Ashbaugh
Thursday’s biggest gaining and declining stocks 4:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 9:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 9:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 10:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 12:00 p.m. July 28, 2011 - MarketWatch.com
Trade-Ideas: Horizon Pharma (HZNP) Is Today's "Perilous Reversal" Stock 9:46 a.m. April 10, 2014 - TheStreet.com
Horizon Pharma (HZNP): An Off-the-Radar Potential Winner - Tale of the Tape 8:33 a.m. April 10, 2014 - Zacks.com
Best- And Worst-Performing Stocks YTD 10:13 a.m. April 2, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – XLRN MYGN HZNP WOOF 7:45 a.m. April 2, 2014 - InvestorPlace.com
Horizon Pharma's CEO Hosts Corporate Update Call 12:00 p.m. March 27, 2014 - Seeking Alpha
Can Horizon Pharma (HZNP) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape 8:47 a.m. March 27, 2014 - Zacks.com
Horizon Pharma Inc Stock Downgraded (HZNP) 11:11 a.m. March 26, 2014 - TheStreet.com
Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook 2:17 a.m. March 26, 2014 - Zacks.com
Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews 2:17 a.m. March 26, 2014 - Zacks.com
Is A Short Squeeze Ahead for Horizon Pharma (HZNP)? - Tale of the Tape 9:18 a.m. March 25, 2014 - Zacks.com
Roundtable Top Picks for the Week of Mar. 24th - Video Blog 4:52 p.m. March 24, 2014 - Zacks.com
Horizon Pharma to Buy Vidara, Shares Rise - Analyst Blog 4:09 p.m. March 20, 2014 - Zacks.com
Horizon Pharma Has Significant Growth Potential 10:28 a.m. March 20, 2014 - Seeking Alpha
Horizon Pharma's CEO Discusses Acquisition of Vidara Therapeutics (Transcript) 4:14 p.m. March 19, 2014 - Seeking Alpha
Why Horizon Pharma (HZPN) Is Up Today 4:00 p.m. March 19, 2014 - TheStreet.com
Horizon Inks Reverse Merger With Vidara 10:30 a.m. March 19, 2014 - FOXBusiness
Horizon Pharma (HZNP) Hits New Lifetime High Today 9:45 a.m. March 19, 2014 - TheStreet.com
Horizon Pharma To Buy Vidara, Join Exodus To Ireland 9:45 a.m. March 19, 2014 - Investors Business Daily
Horizon Pharma to Acquire Vidara in $660 Million Deal 7:49 a.m. March 19, 2014 - The Wall Street Journal Interactive Edition
UPDATE: Horizon Pharma Announces the Purchase of Vidara Therapeutics for $660M in Stock, Cash 6:13 a.m. March 19, 2014 - benzinga.com
Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Horizon Pharma Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets 7:30 a.m. April 10, 2014 - Marketwire
Technical Data on Top Gainers -- Research on JinkoSolar, Horizon Pharma, YY Inc., and Questcor Pharma 9:59 a.m. April 2, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 10:20 p.m. March 27, 2014 - Marketwire
Acquisitions, Appointments, and New Product Developments - Analyst Notes on Boston Scientific, Horizon Pharma, Alkermes, Agilent, and BD 8:00 a.m. March 26, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the 21st Annual Future Leaders in the Biotech Industry Conference 7:31 a.m. March 25, 2014 - Marketwire
Horizon Pharma to Host Corporate Update Meeting on March 27, 2014 7:30 a.m. March 24, 2014 - Marketwire
Horizon Pharma Inc. Acquires Vidara Therapeutics in a Reverse Merger Deal Worth $660M in Cash and Stock 12:30 a.m. March 20, 2014 - ACCESSWIRE
Deerfield Provides up to $250 Million in Acquisition Financing to Horizon Pharma 7:15 a.m. March 19, 2014 - BusinessWire - BZX
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc 7:01 a.m. March 19, 2014 - Marketwire
Market Major Trends - New High: Horizon Pharma, Norfolk Southern, Delphi Automotive, and Solazyme 5:40 a.m. March 14, 2014 - PR Newswire - PRF
Horizon Pharma Reports 2013 Financial Results and Provides Business Update 6:30 a.m. March 13, 2014 - Marketwire
Egalet Appoints Timothy P. Walbert to Board of Directors 8:14 a.m. March 11, 2014 - GlobeNewswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 7:30 a.m. March 6, 2014 - Marketwire
Horizon Pharma to Present at the 26th Annual ROTH Conference 7:30 a.m. March 6, 2014 - Marketwire
Financial Results Releases and Schedules, Clinical Study Results, Partnerships, and Senior-Level Appointments - Analyst Notes on Arena, Horizon Pharma, Enanta, Vanda, and PTC 3:30 p.m. March 5, 2014 - PR Newswire - PRF
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer 7:30 a.m. March 5, 2014 - Marketwire
Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2013 Financial Results on March 13, 2014 7:44 a.m. Feb. 27, 2014 - Marketwire
Horizon Pharma to Present at the Cowen and Company 34th Annual Health Care Conference 7:30 a.m. Feb. 24, 2014 - Marketwire
Horizon Pharma Provides Update on February 10-11, 2014 FDA Joint Advisory Committee Meeting on Cardiovascular Risk of NSAIDs 4:40 p.m. Feb. 11, 2014 - Marketwire
Charting a bullish second-quarter backdrop 12:34 p.m. April 1, 2014 - Michael Ashbaugh
Charting a bullish second-quarter backdrop 12:20 p.m. April 1, 2014 - Michael Ashbaugh
S&P 500 retests major support 12:47 p.m. March 27, 2014 - Michael Ashbaugh
Thursday’s biggest gaining and declining stocks 4:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 9:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 9:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 10:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 12:00 p.m. July 28, 2011 - MarketWatch.com
Trade-Ideas: Horizon Pharma (HZNP) Is Today's "Perilous Reversal" Stock 9:46 a.m. April 10, 2014 - TheStreet.com
Horizon Pharma (HZNP): An Off-the-Radar Potential Winner - Tale of the Tape 8:33 a.m. April 10, 2014 - Zacks.com
Best- And Worst-Performing Stocks YTD 10:13 a.m. April 2, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – XLRN MYGN HZNP WOOF 7:45 a.m. April 2, 2014 - InvestorPlace.com
Horizon Pharma's CEO Hosts Corporate Update Call 12:00 p.m. March 27, 2014 - Seeking Alpha
Can Horizon Pharma (HZNP) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape 8:47 a.m. March 27, 2014 - Zacks.com
Horizon Pharma Inc Stock Downgraded (HZNP) 11:11 a.m. March 26, 2014 - TheStreet.com
Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook 2:17 a.m. March 26, 2014 - Zacks.com
Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews 2:17 a.m. March 26, 2014 - Zacks.com
Is A Short Squeeze Ahead for Horizon Pharma (HZNP)? - Tale of the Tape 9:18 a.m. March 25, 2014 - Zacks.com
Roundtable Top Picks for the Week of Mar. 24th - Video Blog 4:52 p.m. March 24, 2014 - Zacks.com
Horizon Pharma to Buy Vidara, Shares Rise - Analyst Blog 4:09 p.m. March 20, 2014 - Zacks.com
Horizon Pharma Has Significant Growth Potential 10:28 a.m. March 20, 2014 - Seeking Alpha
Horizon Pharma's CEO Discusses Acquisition of Vidara Therapeutics (Transcript) 4:14 p.m. March 19, 2014 - Seeking Alpha
Why Horizon Pharma (HZPN) Is Up Today 4:00 p.m. March 19, 2014 - TheStreet.com
Horizon Inks Reverse Merger With Vidara 10:30 a.m. March 19, 2014 - FOXBusiness
Horizon Pharma (HZNP) Hits New Lifetime High Today 9:45 a.m. March 19, 2014 - TheStreet.com
Horizon Pharma To Buy Vidara, Join Exodus To Ireland 9:45 a.m. March 19, 2014 - Investors Business Daily
Horizon Pharma to Acquire Vidara in $660 Million Deal 7:49 a.m. March 19, 2014 - The Wall Street Journal Interactive Edition
UPDATE: Horizon Pharma Announces the Purchase of Vidara Therapeutics for $660M in Stock, Cash 6:13 a.m. March 19, 2014 - benzinga.com
Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Horizon Pharma Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets 7:30 a.m. April 10, 2014 - Marketwire
Technical Data on Top Gainers -- Research on JinkoSolar, Horizon Pharma, YY Inc., and Questcor Pharma 9:59 a.m. April 2, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 10:20 p.m. March 27, 2014 - Marketwire
Acquisitions, Appointments, and New Product Developments - Analyst Notes on Boston Scientific, Horizon Pharma, Alkermes, Agilent, and BD 8:00 a.m. March 26, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the 21st Annual Future Leaders in the Biotech Industry Conference 7:31 a.m. March 25, 2014 - Marketwire
Horizon Pharma to Host Corporate Update Meeting on March 27, 2014 7:30 a.m. March 24, 2014 - Marketwire
Horizon Pharma Inc. Acquires Vidara Therapeutics in a Reverse Merger Deal Worth $660M in Cash and Stock 12:30 a.m. March 20, 2014 - ACCESSWIRE
Deerfield Provides up to $250 Million in Acquisition Financing to Horizon Pharma 7:15 a.m. March 19, 2014 - BusinessWire - BZX
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc 7:01 a.m. March 19, 2014 - Marketwire
Market Major Trends - New High: Horizon Pharma, Norfolk Southern, Delphi Automotive, and Solazyme 5:40 a.m. March 14, 2014 - PR Newswire - PRF
Horizon Pharma Reports 2013 Financial Results and Provides Business Update 6:30 a.m. March 13, 2014 - Marketwire
Egalet Appoints Timothy P. Walbert to Board of Directors 8:14 a.m. March 11, 2014 - GlobeNewswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 7:30 a.m. March 6, 2014 - Marketwire
Horizon Pharma to Present at the 26th Annual ROTH Conference 7:30 a.m. March 6, 2014 - Marketwire
Financial Results Releases and Schedules, Clinical Study Results, Partnerships, and Senior-Level Appointments - Analyst Notes on Arena, Horizon Pharma, Enanta, Vanda, and PTC 3:30 p.m. March 5, 2014 - PR Newswire - PRF
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer 7:30 a.m. March 5, 2014 - Marketwire
Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2013 Financial Results on March 13, 2014 7:44 a.m. Feb. 27, 2014 - Marketwire
Horizon Pharma to Present at the Cowen and Company 34th Annual Health Care Conference 7:30 a.m. Feb. 24, 2014 - Marketwire
Horizon Pharma Provides Update on February 10-11, 2014 FDA Joint Advisory Committee Meeting on Cardiovascular Risk of NSAIDs 4:40 p.m. Feb. 11, 2014 - Marketwire
(0)
(0)